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Chapter 1 Iron, sulphur and iron-sulphur cluster
biogenesis
1.1 Introduction
Trace elements constitute only 0.15% of the mass of the human body; yet,
more than a dozen of them are indispensable for sustaining life in a cell. Iron is one
such vital trace element. In humans, approximately 50-60% of this iron is a
constituent of haemoglobin. The remaining iron is incorporated in the cell’s ferritin
reserves by means of haemoglobin recycling and distributed intracellularly when
required [2]. Iron, being a natural electron acceptor or electron donor, is highly
reactive and hence, in its free form is extremely toxic to the cell. Any imbalance in
human iron metabolism leads to iron deficiency or iron overload and triggers the
release of free iron. These possibilities are witnessed through the pathophysiology of
diseases like Friedreich’s ataxia, ISCU myopathy, a rare form of sideroblastic anemia
and Respiratory complex I-associated encephalomyopathy (where iron accumulation
is a common feature) and, Anemia (where iron deficiency is the cause) [3].
Another reactive species critical for the survival of a human cell is sulfur and
it is of significance because it readily forms bonds with iron and other trace
elements. Sulfur reserves in the body are slightly higher than iron reserves as it
constitutes the list of elements that make up 0.85% of the human body mass. Of the
available non-metals in the body, sulfur is only next to phosphorus in its versatility of
reactivity. This makes sulfur an integral part of many vital proteins, carbohydrates,
cofactors and metabolites. Consequently, sulfur needs to be regulated through
sulphur metabolism. A human cell acquires sulphur in the form of the amino acids -
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cysteine and methionine, and any imbalance in sulphur metabolism would lead to
sulphur overload or sulphur deficiency. However, the effects of sulphur overload are
not prominent in any diseased state because the human body has an efficient
mechanism to excrete sulfur in the form of sulphate through urine, unlike iron that
does not have a physiological mechanism to eliminate excess iron[4]. In contrast,
sulfur deficiency has multiple side effects on human physiology. When methionine is
depleted,

the

transsulfuration

pathway

for

cysteine

biosynthesis

and

transmethylation pathway for homocysteine biosynthesis is affected[5]. Cysteine’s
bioavailability depends entirely on methionine intake, the depletion of which causes
oxidant stress due to glutathione (a tripeptide antioxidant containing cysteine) and
taurine (antioxidant) inadequacy[6]. Intestinal villus atrophy and low intestinal crypt
depth due to limited cell proliferation and high apoptosis (oxidant stress-associated)
are therefore, symptoms of methionine deficiency [6].
Owing to the reactivity of these two chemical species, one would be tempted
to wonder what they could form in each other’s company and whether this
complexation would be beneficial to the human cell in any way. This brings us to the
exciting field of iron-sulfur cluster chemistry. Infact, it appears as though nature has
evolved an elegant mechanism, by allowing iron sulfur cluster (or Fe-S clusters)
formation, to circumvent the problems arising from free iron and free sulfur
reactivity in the cell.
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1.2 Background
Until the mid-60s iron was believed to be a cofactor in all iron-containing
proteins. Simple spectral studies which were performed previously had
demonstrated that some of these proteins had extinction coefficients lower than
heme proteins at around 400nm[7]. With the development of Infrared spectroscopy,
Mossbauer spectroscopy, EPR and ENDOR spectroscopy, these intriguing ironcontaining proteins were found to be actually iron-sulfur proteins[8], and they
constituted such a vital cohort of proteins that they could not be ruled out as
‘exceptions’. Structurally, these proteins could accommodate clusters in the form of
2Fe-2S, 3Fe-3S, 3Fe-4S, 4Fe-4S, 8Fe-7S and 8Fe-8S. To add to their diversity, these
clusters could exhibit different redox states like [2Fe-2S]2+, [2Fe-2S]+, [3Fe-4S]2+,
[3Fe-4S]+, etc.[8] Some of these proteins were found to house more than one type of
cluster; others could house one Fe-S cluster and metal ions. This structural diversity
constituted by diverse Fe-S protein folds and its link with protein stability is an
emerging field in coordination chemistry[9].
Individually, these iron sulfur clusters could be produced in vitro and like their
precursors were found to be extremely versatile. They were originally thought to be
“sensitive” molecules as they degraded in the presence of dioxygen. This notion
changed when methods using mild denaturants and carrier thiols were designed to
extrude these clusters from different apoproteins[10]. They were also remarkably
capable of conversion and interconversion in both the free and protein-bound
conditions [10].This meant that they could swap cysteine ligands in proteins with or
without cluster conversion. In the protein-bound form, they could facilitate substrate
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activation (Aconitase), electron transfer (Respiratory complexes I, II, III),
environmental oxygen sensing (Fumarate-Nitrate Reduction protein), DNA repair
(Base excision repair glycosylases), ribosome assembly (ABCE1 protein), DNA-RNA
processing (helicases, DNA polymerases, telomere length regulator proteins), tRNA
thiolation and even, iron regulation (iron regulatory protein). This exemplifies their
usefulness in most of the life sustaining phenomena inspite of constituting only a
tiny fraction of the human body mass. Researchers have also identified diseases
associated with Fe-S clusters. A list of diseases for Fe-S clusters is provided in Table
1. For its tremendous influence on myriad pathways, it would be surprising if we did
not witness these iron-sulfur clusters in the most primitive life forms on earth.
Today, they offer excellent cues to predict the molecular basis of the origin of life
and reaffirm the concepts of evolution[11].
Despite these major breakthrough discoveries about their nature, their
reactivity, their distribution and their usefulness, one prominent question remained,
‘Were these clusters made in the cell or were they acquired from the external
environment?’. It took the scientific community another thirty years for this question
to be answered when Dean and co-workers identified a set of nif genes whose
proteins were found to participate in cluster formation for the Nitrogenase enzyme
in A.vinelandii[12]. The puzzle was solved and slowly key players of this process were
uncovered one by one!
1.3 Cell-specific differentiation of the pathway
Today, we know that prokaryotes have three different pathways for iron
sulfur cluster biogenesis; whereas, eukaryotes have two different iron-sulfur cluster
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Human protein

Function

Associated disease

Biogenesis components
Mitoferrin
ISCU
Frataxin
GLRX5

ADR
ABCB7 (Atm1
homolog)

Putative iron
transporter
Mitochondrial
scaffold
Iron donor for ISCU
scaffold
Transfer of Fe-S
cluster from ISCU to
apoprotein
Electron transfer
ISC export machinery
component, ABC
transporter

Erythropoietic protoporphyria

Complex I of
respiratory chain
Complex II of
respiratory chain
Fe-S protein involved
in nucleotide excision
repair
Fe-S protein involved
in nucleotide excision
repair
Fe-S
protein(glycosylase)
involved in DNA
repair

Various mitochondrial diseases such as
LHON, MELAS and Leigh syndrome
Tumor suppressor

Myopathy with exercise intolerance
Friedreich’s ataxia
Microcytic anaemia

Tumor suppressor
X-linked sideroblastic anaemia and
cerebellar ataxia

Fe-S proteins
Complex I
Complex II
XPD

FANCJ

MUTYH

Xeroderma pigmentosum, Cockayne
syndrome, trichothiodystrophy
Fanconi anaemia

Colon cancer

Table 1: Diseases associated with Iron-sulfur cluster biogenesis and Fe-S
proteins
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biogenesis pathways. In prokaryotes, the pathways are distinguished based on
functional significance into the Isc (Iron sulfur cluster) system, Nif (Nitrogen fixation)
system and the Suf (Sulfur formation) system. The NIF system is exclusively for iron
sulfur cluster maturation for the nitogenase enzyme in nitrogen fixing bacteria. The
SUF system is exhibited under conditions of iron depletion in a cell. The pathway that
closely resembles the eukaryotic pathways is the ISC pathway. However, the
phylogenetic distribution of these pathways is complicated. For example, organisms
such as Mycobacterium tuberculosis and few archaea, appear to have the Suf system
alone; whereas, in Escherichia coli the Isc system is more important than the Suf
system[13].
In eukaryotes, however, the pathway is classified into cytosolic and
mitochondrial based on subcellular compartmentalization. The cytosolic pathway is
known as the CIA machinery. So far, its mitochondrial counterpart – the ISC
biogenesis pathway, is regarded as the main pathway for iron sulfur cluster
biogenesis in eukaryotes. Interestingly, the human mitochondrion that is believed to
have only 13 mitochondrial proteins[14], imports nuclear proteins for the fulfilment
of iron sulfur cluster maturation. Figure 1.1 and 1.2 highlight all the key proteins of
both the eukaryotic pathways.
Our understanding of all these pathways is very primitive as can be seen from
the relaxation in classification strategy for prokaryotes and eukaryotes; while the
former is functionally distinguished, the latter is subcellular distribution-based. [No
correlation has been postulated between the subcellular occurrence of proteins that
are benefited from the pathways and the subcellular predominance of the pathways
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FIGURE 1.1: Key players of the Eukaryotic mitochondrial ISC biogenesis
pathway
Iron (red circle) is first transported into the mitochondrion with the help of
monothiol glutaredoxins and inner membrane transport proteins, Mrs 3-Mrs4.
This iron is presumably collected by Frataxin which binds to Isu1 in an irondependent manner where its role is either to donate iron or to allosterically
regulate Nfs/Isd11 activity. Nfs/Isd11 is the sulphur (yellow circle) donor for the
assembly step. An electron transfer unit comprising ferrerdoxin (Yah1),
ferredoxin reductase (Arh1) and NAD(P)H is also needed to accomplish Fe-S
cluster assembly. In the second step, transiently-bound 2Fe-2S cluster is
removed from Isu1 by a chaperone system of ATP-dependent Hsp70 chaperone
Ssq1, its co-chaperone Jac1 and nucleotide exchange factor Mge1 and
transported either by a Grx5-Glutathione complex or by a Ferredoxin complex to
target apoproteins. In the third step, these 2Fe-2S clusters are differentiated
into 4Fe-4S clusters with the help of Iba57, Isa1 and Isa2 and supplied to specific
proteins like Lipoate synthase and Aconitase. Simultaneously, a Fe-S cluster
intermediate is transported through transporter Atm1 to the cytosol for the CIA
machinery. The CIA machinery uses 7 proteins to accomplish Fe-S cluster
biogenesis for some cytosolic and nuclear proteins.
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FIGURE 1.2: Key players of the eukaryotic CIA machinery and the physical link
between ISC biogenesis pathway and the CIA machinery
A Fe-S intermediate from the mitochondria is transported through the ABC
transporter Atm1 to the cytosol. This step is aided by sulfhydryl oxidase Erv1
and Glutathione. The source for Fe is still not known. In the first step, Fe-S
cluster is assembled on the P-loop NTPase complex Cfd1-Nbp35. This
transiently-bound Fe-S cluster is transferred to specific apoproteins by
proteins Nar1 and Cia1.
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Function

Bacterial
NIF
NifS

Bacterial
SUF
SufS-SufE

Bacterial
ISC
IscS

Cysteine
desulphurase,
sulphur
donor
U-type
NifU (NSufU
IscU
scaffold for
terminal
assembly
domain)
A-type
IscA
SufA
IscA, ErpA
scaffold for
assembly
NFU-type
NifU(CNfuA
scaffold for
terminal
assembly
domain
P-loop
NTPase
scaffold for
assembly*
Electron
NifU(middle Fdx
transfer
domain)
Iron donor
CyaY
Transfer of
SufC?
HscA,
Fe-S cluster
HscB
from scaffold
to target
apoproteins
* - Phosphate-binding-loop Nucleoside triphosphatases

Mitochondrial Eukaryotic
ISC
CIA
Nfs1-Isd11
Mitochondrial
Nfs1-Isd11

Isu1

-

Isa1, Isa2,
Iba57?

-

Nfu1

-

Ind1?

Cfd1-Nbp35

Yah1-Arh1

-

Yfh1
Ssq1, Jac1,
Mge1, Grx5

Nar1, Cia1

Table 2: Comparison of prokaryotic and eukaryotic proteins involved in the iron
sulfur cluster biogenesis pathways
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themselves.] This permits us to look at the similarities in the proteins involved in
prokaryotic and eukaryotic ISC biogenesis pathways. Table 2 lists the prokaryotic
proteins in the pathways and its eukaryotic counterparts. The mitochondrial ISC
biogenesis pathway in eukaryotes will be the focus of this manuscript.
1.4 General mechanism of mitochondrial Iron Sulfur Cluster biogenesis
The eukaryotic mitochondrial iron sulfur cluster biogenesis pathway is called
the ISC biogenesis pathway. The pathway takes place in the mitochondrial matrix
and is understood in three major steps – iron-sulfur cluster assembly, iron-sulfur
cluster transfer and iron-sulfur cluster delivery. Seventeen proteins have been
identified so far in this pathway [15] and a detailed account of the general
mechanism of the pathway is required for further discussion. The steps involved are
outlined below.
Firstly, Cysteine desulfurase and its accessory protein, Isd11, in a PLPdependent mechanism, deliver sulfur to a scaffold protein, Isu1. Simulatenously, iron
loaded-Frataxin is believed to deliver iron to the same scaffold protein. It is not yet
known whether sulfur delivery or iron delivery is the rate-limiting step in iron-sulfur
cluster assembly [16]. Once the precursors arrive at Isu1 and are brought into each
other’s vicinity, through elegant conformational changes of the entire Cysteine
desulfurase-Isd11-Isu1-Frataxin complex, the genesis of 2Fe-2S clusters occurs.
These events involved in the formation of a 2Fe-2S cluster, also known as ‘iron-sulfur
cluster assembly’ constitute the first step of the pathway.
After assembly of 2Fe-2S clusters on Isu1, these clusters that are transiently
bound to Isu1 are first removed, then transported and finally, assembled on target
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apoproteins by Cluster Transfer Proteins. Although these three partial steps are
difficult to isolate experimentally, iron-sulfur cluster dissociation from Isu1 is
believed to occur through the ATP-hydrolysis dependent complexation of an ATPase
chaperone, Ssq1 and its co-chaperone Jac1 on the PVK domain of Isu1[1]. The ratelimiting step in the entire pathway is believed to be the cluster transfer step from
IscU (bacterial homolog of Isu1) [17]. Apart from these three steps, there is an
additional step when some of these 2Fe-2S clusters are differentiated into 4Fe-4S
clusters for specific apoproteins. Isa1, Isa2 and Iba57 are few proteins involved in
this additional step[1]. This entire event is broadly categorized as the second major
step – the ‘iron-sulfur cluster transfer’ step.
In the final step, iron-sulfur cluster-bound proteins are transported outside
the mitochondria with the help of ATP transporters and other proteins. Also, some
Fe-S cluster intermediate alone is believed to be transported outside the
mitochondria probably, to aid the cytosolic pathway.
1.5 The organic half of the pathway – Sulfur delivery
Bacterial NifS was the first protein of the ISC biogenesis pathway that was
identified and biochemically characterized[13]. Subsequently, two other cysteine
desulfurases IscS and SufS were discovered. All three proteins are similar in
sequence and structure and follow a similar persulfide formation strategy to extract
sulfur [13]. Biochemical studies suggest that their eukaryotic homologs like Nfs1
(yeast), NFS1 (human-mitochondrial) and ISCS (human-cytosolic) also follow a similar
strategy. Figure 1.3 shows the crystal structure of bacterial IscS. Some significant
facts derived from the crystal structure of bacterial IscS are [18]:
1. L-Cysteine is its reactive substrate.
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2. They are homodimers with a Pyridoxal-5’ phosphate (PLP) group attached at
the dimer interface.
3. Each monomer has two domains. The larger domain has the conserved active
site lysine residue and the smaller C-terminal domain houses a reactive
cysteine residue.
4. The reactive cysteine is easily blocked by alkylating agents like N-ethyl
maleimide (NEM) and this renders the enzyme inactive.
5. Substitution of this reactive cysteine by alanine also renders this enzyme
inactive.
The general steps involved in sulfur delivery by cysteine desulfurase are as
follows[19]:
1. First, PLP binds to an active site, lysine rearranges and forms a ketimine
adduct with the substrate L-cysteine.
2. Next, the thiolate group of the reactive cysteine residue in the smaller Cterminal flexible loop of the enzyme attacks the PLP-bound cysteine by
nucleophile chemistry.
3. A series of bond shifts between the reactive cysteine residue and the PLPcysteine adduct leads to the extraction of the thiolate group of the substrate
by the reactive cysteine to form an enzyme-bound persulfide intermediate.
4. The substrate cysteine devoid of its SH group results in the formation of an
alanine-PLP adduct.
5. The mechanism by which alanine is released from PLP is not known yet.
6. Once persulfide is formed, the proximal sulfur/sulfide group is transferred to
conserved cysteine residues on Isu1.
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7. Latest evidence shows that this transfer of persulfide to Isu1 occurs only in
the presence of iron and nucleotides like ATP and GTP[20].
8. The mechanism of this PLP-mediated sulfur extraction reaction of cysteine
desulfurase is called beta-elimination.
9. Lastly, the eukaryotic homolog of this enzyme is inactive in the absence of an
accessory protein named Isd11.
1.6 Other roles of cysteine desulfurase and subcellular distribution
Apparently, cysteine desulfurase is not an enzyme used exclusively by the
cytosol or mitochondria for Iron sulfur cluster biogenesis. The enzyme is also found
to play a major role in tRNA thiolation [21]. Moreover, it is involved in the
biosynthesis of major cellular cofactors like thiamin, biotin, lipoic acid and
molybdenum cofactor[1]. These additional attributes can be considered as the
enzyme’s moonlighting functions in other cellular processes[1]. Thus, a defect in
cysteine desulfurase can have a major impact on multiple pathways within a cell. An
alternative viewpoint that was suggested previously was that cysteine desulfurase
plays a major role in intracellular sulfur trafficking[13].
With their involvement in multiple cellular processes it would be reasonable
to assume that this enzyme is present in all three compartments of the cell – the
cytosol, the nucleus and the mitochondrion. Although in humans this is the case, in
yeast, the enzyme is found only in the mitochondria and is believed to shuttle
between the cytosol and mitochondria for their respective iron sulfur cluster
biogenesis pathways[22]. This could possibly mean that in higher eukaryotes the
enzyme is more widespread as opposed to the lower eukaryotes like yeast.
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Figure 1.3: Ribbon-shaped diagram showing the Crystal structure of IscS
The diagram shows the dimeric subunits of cysteine desulfurase with an
active site PLP (pyridoxal 5’ phosphate) at its dimeric interface. Figure taken
from [18]
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1.7 Cysteine desulfurase’s accessory protein - Isd11 and other LYR proteins
The only major anomaly in the assembly step of eukaryotic Fe-S cluster
biogenesis pathways is the presence of an 11kDa protein named Isd11. Isd11 is
found exclusively in eukaryotes [23] and is an ancient protein. Homologs are found in
the mitosomes of Microsporidia and the hydrogenosomes of Trichomonads, which
are organelles that originated before the mitochondrion[11]. Different experimental
approaches on cell viability have suggested that yeast Isd11 is a strictly essential
protein for the cell [23]. Hence, Isd11 belongs to the small fraction (18%) of cellular
proteins that are strictly essential for yeast cell viability [24]. The reason for its
indispensable role in the cell can be attributed to its association with cysteine
desulfurase and its unique ability to activate the protein. Latest evidence suggests
that persulfide formation in the active site of cysteine desulfurase occurs only in the
presence of Isd11 [25]. This is one of the main features that distinguishes eukaryotic
iron sulfur cluster assembly from its prokaryotic counterpart.
Although Isd11 has no mitochondrial signal sequence, it exists primarily in the
mitochondrial matrix and is loosely connected with the inner membrane [23]. Recent
evidence suggests that a nuclear version of the protein also exists, consistent with
the subcellular distribution of cysteine desulfurase [26]. This finding is consistent
with the observation that Isd11 is essential for the biogenesis of mitochondrial and
nuclear Fe-S clusters [23], although its involvement in cytosolic Fe-S cluster
formation still needs to be addressed.
A notable feature of Isd11 is that it belongs to the poorly conserved LYR
family of proteins [27]. Interestingly, a common functional trait for this family of
proteins has not been found yet [23]. Other members of this family of proteins
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include Mzm1, SDHAF1 (Respiratory Complex II subunit), NDUFA6 (Respiratory
Complex I subunit) and NDUFB9 (Respiratory Complex I subunit). The functional
significance of few of these LYR proteins like Mzm1, SDHAF1, NDUFA6 and NDUFB9
suggest that the LYR motif and Fe/S cluster metabolism have some correlation.
1.8 Cysteine desulfurase – Isd11 complex
Some information on the Isd11-Nfs complex is available today. Copurification of the complex using size-exclusion chromatography has shown that it
exists as a 180-200kDa protein complex [27]. In-vivo studies have shown that Isd11
binding on cysteine desulfurase is independent of substrate cysteine binding [17]. In
addition, inactivation of cysteine desulfurase by the alkylating agent NEM is not
possible at low concentrations. The same group also found that the LYR motif of
Isd11 is essential for Isd11 binding and subsequent activation of cysteine desulfurase
[17]. Finally, as stated above, recent evidence suggests that Isd11 binding is a
prerequisite for eukaryotic cysteine desulfurase activity and persulfide formation
[25].
A lot has been known in the past six years about the coordinated functioning
of the Isd11-Nfs complex. Still, a lot of questions remain unanswered. Some of the
questions are: Why is Isd11 exclusively found in eukaryotes? Why does the
eukaryotic system need an extra protein for sulfur extraction? What changes occur
in the Iron sulfur cluster biogenesis pathway if methionine or cysteine is depleted?
Does Isd11 play a role in other pathways without the involvement of cysteine
desulfurase? With steady developments in this field every year, we can remain
hopeful that the entire mechanism will be deciphered to a large extent in the near
future.
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Chapter 2 Characterisation of DIsd11
2.1 Prelude
Isd11 is a nuclear-encoded, 11kDa mitochondrial protein that localizes in the
mitochondrial matrix after its biosynthesis [1]. Surprisingly, the protein has no
mitochondrial targeting sequence and yet, enters the matrix of the organelle [1, 2].
Another notable feature of this protein is that it has no cysteines and no tryptophans
in its protein sequence. This eliminates the possibility of performing a fluorescence
spectroscopy experiment on this protein. Also, every spectroscopic technique that
majorly relies on light absorption by the tryptophan residues of proteins to
quantitatively estimate its biochemical properties would be inaccurate for Isd11.
However, there are certain intrinsic benefits as well. The lack of cysteine residues in
the protein eliminates the possibility of a Fe-S cluster binding within it and also,
allows us to eliminate the empirical errors that can cause unfolding of the protein by
disulfide bond breakage.
Isd11 has been found to activate eukaryotic cysteine desulfurase both in vivo
and in vitro. This was accomplished by A. Dancis et al. and D. Pain et al. [3] through
two elegant experiments. Before this study, other research groups claimed that
Isd11 has no effect on cysteine desulfurase activity. However, the activity assay used
for the earlier claims were highly insensitive as it detected the overall microsulfide
concentrations in the mitochondria on Isd11 depletion. The basis for following such a
strategy was that Nfs1 is the only known eukaryotic cysteine desulfurase in the
mitochondrion [4] and hence, any sulphide produced could be only from cysteine
desulfurase. When a radioactive assay that specifically detects persulfide formation
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was developed, these assumptions were proven wrong. In the first experiment, a
yeast mitochondrion expressing Nfs1p was depleted of Isd11p and tested for
persulfide formation and later, purified Isd11 was imported into the same depleted
mitochondrion to test if this effected a change. In the first case, no persulfide
formed; whereas, in the second case, persulfide appeared and increased in intensity
over time. To test the same phenomenon in vitro, purified Nfs1p was incubated with
S35-cysteine and tested with and without Isd11. The results of the in vivo experiment
correlated with the in vivo experiment. This confirmed that Isd11p is a prerequisite
for yeast Nfs1p activation and persulfide formation and at the same time was not
required for binding of substrate cysteine with Nfs1p.
Biochemical characterization of Isd11 is critical for understanding the
protein’s activity. Like the experiments discussed above, more biochemical
experiments are required for further characterization of the protein. Simultaneously,
it is also important to perform biophysical characterization of Isd11 to predict the
structure of the protein. Prediction of a protein’s structure is the ultimate milestone
in understanding a protein’s functionality. Presently, the crystal structure of Isd11 is
not known. Preliminary biophysical characterization before solving Isd11’s crystal
structure involves studying the folded state of the protein, its oligomeric properties
and its thermal stability. To accomplish these tasks, Drosophila melanogaster was
chosen as a model organism in our lab.
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2.2 Materials and Methods
2.2.1. Cloning of DIsd11
DIsd11 cDNA was obtained in a pFLC1 vector, from the Drosophila Genomic
Research Center (FlyBase ID: FBcI0223918). DIsd11 cDNA was PCR amplified and subcloned into a pET14b vector (Novagen) which has a (His)6 tag and an Ampicillin
resistance ‘bla’ gene. The cloned plasmid was amplified by transforming into DH5α
cloning strain (Invitrogen). The DIsd11 sequence represents 107-385bp of the
complete 705bp open reading frame. Positive clones were verified by DNA
sequencing (Genewiz facility). Recombinant plasmid was transformed into BL21
(DE3)-RIL (Stratagene), BL21 (DE3)–Rossetta (Novagen) and BL21 (DE3) E.coli
competent cell lines for protein expression.
2.2.2. Optimization of soluble protein expression
The cell line with best soluble protein expression was identified as BL21 (DE3)
by growing at 37°C till an OD of 0.8 and then inducing with 0.4mM IPTG for ca. 2
hours. The next step was to optimize protein expression in the selected cell line,
BL21 (DE3). DIsd11 soluble protein expression was optimized by varying IPTG
concentrations, post-induction time intervals, pre-induction OD and Temperatures.
Optimum protein expression was obtained when BL21 (DE3) was grown at 37°C till
an OD of 0.8-0.9 and then induced with 0.2mM IPTG for ca. 2.5 hours before
harvesting by centrifugation.
2.2.3. Soluble DIsd11 protein purification
Protein isolation steps were all performed at 4° C. Cells were resuspended in
50 mM Na3PO4 (pH 7.4), 300 or 500mM NaCl, 20 mM Imidazole and 5 mM β-Me in
the presence of Complete EDTA-free Protease inhibitor cocktail (Roche). Cells were
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then lysed by two passes through a French Press cell at high pressure (1100 psi), and
centrifuged at high speed (21000 rpm) for 1 hour. Crude soluble fraction was filtered
(0.20 μm) and loaded onto a HisPur Cobalt column (Thermo Scientific) using an
Imidazole gradient in the range of 0 – 500 mM (DIsd11 protein elutes between 260
and 380mM). DIsd11 containing fractions were pooled and concentrated to ca. 1mL
by centrifugation using 3kDa Molecular Weight Cut Off (MWCO) centricons
(Millipore) spun at 5000 rpm. The concentrated retentive solution was run over a
HiLoad 16/10 Superdex 75 size exclusion column (General Electronics) equilibrated
with 50mM Na3PO4 buffer (pH 7.4), 500 mM NaCl. Following this protocol, DIsd11
monomer and oligomers were obtained based on SDS-PAGE gel analysis (Bio-Rad).
The obtained protein concentration was 0.5 – 0.6 mg/mL and could be stored
anaerobically at -20° C, for several weeks and slight degradation appeared only after
three months.
2.2.4. Western Blot using Anti-His antibody and Anti-Isd11 antibody
The western blot experiment was done over two days. On day 1, protein
samples were run on SDS-PAGE gels, stained in Coomassie Blue and checked for
purity of loaded samples. Simultaneously, another gel containing the same protein
samples was left unstained and blotted on a 0.2μm Nitrocellulose membrane (BioRad). Blotting was performed in three steps: firstly, the Mini Trans-Blot filter paper
(Bio-Rad), Mini Trans-Blot filter pads (Bio-Rad), the nitrocellulose membrane and the
unstained gel were soaked in Transfer Buffer (60.5g Tris base , 288g Glycine, 10g SDS
dissolved in 2L water and further diluted with 600mL methanol and 2.16L of water)
for 15 minutes. In the second step, all the above-mentioned blotting components
were stacked on a gel plate and placed in a plastic cassette with the gel facing the

24

black side of the cassette. After assembly, this cassette was placed inside a plastic gel
frame with the black side of the cassette facing the black side of the frame. The gel
frame was then almost completely immersed in Transfer buffer and allowed to run
at 22V overnight in the cold room.
On day 2, the transfer cassette was pulled out of the chamber and a Ponceau
red dye staining of the blotted membrane was performed. This was followed by
washing the membrane in water and blocking the membrane with blocking buffer [5
%(w/v) non-fat dry milk dissolved in 1X TBST buffer – 50mM Tris-HCl(pH8.0), 150mM
NaCl and 0.05% Tween20] for 30 minutes to prevent non-specific binding of the
primary antibody. The Ponceau staining step was optional and was only used to
check the proper transfer of proteins to the membrane. The blotted nitrocellulose
membrane was then incubated in a 1:3000 dilution of primary Anti-His antibody or
Anti-Isd11 antibody in blocking buffer for 3 hours. After the three-hour incubation
period, the membrane was washed 3 times with 1X TBST buffer. After this step, the
membrane was incubated in a 1:5000 dilution of secondary antibody in blocking
buffer (Non-fat dry milk dissolved in 1X TBST) for 1 hour. Following secondary
antibody incubation, the membrane was again washed 3 times with 1X TBST buffer.
The membrane was developed using a mixture of Luminol and Peroxidase (1ml each
for 1min.) and analysed using a CCD camera.
2.2.5. Circular Dichroism of DIsd11 oligomer-monomer mixture
Purified DIsd11 protein was completely dialysed into degassed 1mM NaPO4.
Protein concentration was estimated using Advanced Protein Assay and Lowry Assay.
The dialysed protein was then degassed for 15 minutes using a Thermovac degassing
system. A Camphor Sulfonic acid control was performed to check the proper
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functioning of the UV lamp of the Applied Photophysics CD instrument. After testing
the lamp, a 1mM NaPO4 buffer absorbance spectrum and CD spectrum were taken
using π*180 software from 340nm to 180nm. Then, six CD spectra of the DIsd11
protein in 1mM NaPO4 buffer were collected using the same program. Each DIsd11
CD spectrum was buffer-subtracted and the six scans were averaged to obtain an
averaged CD profile. The resulting profile was smoothed, saved and then processed
using ProData viewer and CDNN softwares.
2.3 Results and Discussion
2.3.1. Cloning of DIsd11
DIsd11 was successfully cloned into pET14b (Figure 2.1), restriction digested
after cloning (Figure 2.2) and sequence analysed to confirm the presence of the
DIsd11 gene in the vector (Figure 2.3). This confirmed that the selected DH5α cloning
strain transformants and the selected BL21(DE3) expression strain transformants had
the right clone.
2.3.2. Optimization of soluble protein expression
The purified plasmid was transformed into three expression strains –
BL21(DE3), BL21(DE3)-RIL and BL21(DE3)-Rossetta (Figure 2.4). The protein
expression from BL21(DE3) alone was optimal. Hence, BL21(DE3) was used for
subsequent expression tests. After a series of expression tests it was found that
soluble DIsd11 is obtained in high yields when BL21(DE3) is grown at 37ᵒC at a preinduction OD of 0.8-0.9 and induced with 0.2mM IPTG for 2 hours (Figure 2.5). Figure
2.6 shows a flowchart for all the expression conditions tried out. The condition for
best soluble protein expression was used for large scale protein expression and
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Figure 2.1: Restriction site map of vector pET14b
The vector has an Ampicillin resistance gene and a (His)6 tag
that attaches to the N-terminus of any protein expressed from
the gene inserted into its Multiple Cloning Site.
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Figure 2.2: Agarose gel showing the DIsd11 gene after cloning into pET14b
vector
A Restriction digestion analysis of the newly cloned pET14b was done to see if
the DIsd11 gene was correctly inserted into the vector. Lanes 2 and 4 show that
in colonies 1 and 3 the DIsd11 gene was cloned into the vector. Lane 3 shows
that in colony 2, DIsd11 gene was not cloned into the vector.
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Figure 2.3: Protein sequence alignment of DIsd11 with the protein sequence
available on Pubmed
The DIsd11 gene was sent to the Genewiz facility for sequence verification. The
obtained gene sequence was translated into its protein sequence using the
Expasy translate program and aligned with the available Pubmed protein
sequence for DIsd11 (RE5789) using the ClustalW2 program. The sequence
alignment shows 100% identity.
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Figure 2.4: SDS-PAGE gel showing DIsd11 protein expression after transforming
into three different E.coli strains
The newly cloned DIsd11 gene was transformed into three E.coli strains –
BL21(DE3) RIL, BL21(DE3) Rossetta and BL21(DE3). ‘P’ stands for Pre-induced and
‘I’ stands for Induced. Lanes 2-11 are Pre-induced and Induced samples for
DIsd11-transformed BL21(DE3)-Rossetta strain. Lanes 12 and 13 are Pre-induced
and Induced samples for DIsd11-transformed BL21(DE3) strain.
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Figure 2.5: Optimization of soluble DIsd11 protein expression
DIsd11 was best expressed at 0.2mM IPTG, 0.9OD, 37ᵒC, 2 hours. Lanes 2-5
correspond to samples from the best expressed condition. Lane 4 shows best
soluble protein expression. ‘PI’ – Pre-induced, ‘I’ - Induced, ‘S’ – Supernatant and ‘P’
– Pellet.
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Variable:

IPTG

Temperature

Time

OD

Figure 2.6: Flowchart of different expression conditions for DIsd11
protein expression in BL21(DE3)
The boxes marked in red highlight the condition for best soluble protein
expression.
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harvesting. A vital point to be noted is that in every SDS-PAGE gel the Isd11
monomer ran at ~15kDa instead of 13.5kDa (with the tag). This was confirmed by
comparing the target samples with the induced samples of Isd11.
2.3.3. Protein purification of soluble DIsd11
Protein purification was the next step and after two rounds of purification
through HisPur Cobalt and HiLoad 16/10 Superdex 75 columns, DIsd11 monomer
could not be isolated. The protein consistently eluted out with four other proteins of
higher molecular weights (Figures 2.7). On increasing the pH to 9.14 there seemed to
be no difference in the purity of the protein (Figures 2.8). Multiple other strategies
were adopted for solving the problem of co-elution. In one strategy, a nutrient-rich
growth medium, Terrific broth (Mo Bio Laboratories) was used for cell growth.
Although the overall soluble protein expression was high, the co-eluted proteins
could not be separated effectively (Figure 2.9). There appeared to be some DIsd11
monomer, but this was not sufficient for the proposed experiments. The co-eluted
proteins were assumed to be oligomers of DIsd11 monomer because literature
suggests that Isd11 has a tendency to exist as oligomers with cysteine desulfurase in
the cell. In a second strategy, the purified protein was dialysed using a Micro Bio-spin
6 column into 7 different co-solvents, each of which was dissolved in a 1mM ZnSO4,
50mM Tris-HCl (pH 8.0) and 150mM KCl buffer. The co-solvents used were 1M Urea,
10mM DTT, 1%TFA, 1M Cysteine, 10%DMSO, 40%Methanol, 5% α-D-glucose (Table
3). None of the samples showed a significant difference suggesting that the
supposed oligomers were probably not reversible after purification (Figure 2.10).
However, a limitation to this conclusion could be that Zinc was a constituent of the
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Figure 2.7: Soluble DIsd11 protein purification using His-Co column affinity
chromatography and S75 Size-exclusion chromatography at pH 7.4
In Figure A., lanes 2-7 correspond to different fractions from His-Co affinity
chromatography purification at a pH of 7.4. Lanes 3, 4 and 5 show that the DIsd11
monomer protein co-eluted with four other proteins after His-Co affinity
chromatography between a gradient of 296mM and 386mM Imidazole. Lanes 3-7
were concentrated and loaded onto an S75 size-exclusion chromatography column.
In Figure B., lanes 2-6 correspond to serially diluted fractions of DIsd11 protein after
S75 size-exclusion chromatography. Lane 2 is a highly concentrated DIsd11 protein.
Lanes 3-6 are serially diluted fractions of the Lane 2 sample.
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Lanes 1 2 3 4 5 6 7 8 9 10 11 12 13 Lanes 1 2 3 4 5 6 7 8 9
Figure 2.8: Soluble DIsd11 protein purification using His-Co column affinity
chromatography and S75 Size-exclusion chromatography at pH
9.14
In Figure A., lanes 2-14 correspond to different fractions from His-Co affinity
chromatography purification at a pH of 9.14. As shown in lanes 9-14, DIsd11
monomer protein primarily co-eluted with two other proteins after His-Co
affinity chromatography between a gradient of 110mM and 373mM
Imidazole. Lanes 9-14 and lanes 7-8 were separately concentrated and loaded
onto an S75 size-exclusion chromatography column.
In Figure B., lanes 2-9 correspond to serially diluted fractions of DIsd11
protein after S75 size-exclusion chromatography. Lanes 2 and 6 correspond to
highly concentrated DIsd11 protein. Lanes 3-5 are serially diluted fractions of
the Lane 2 sample. Lanes 7-9 are serially diluted fractions of the Lane 6
sample.
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Figure 2.9: Terrific broth-grown soluble DIsd11 protein purification using His-Co
column affinity chromatography and S75 Size-exclusion
chromatography
In Figure A. lanes 2-7 correspond to different fractions from His-Cobalt affinity
chromatography purification. In lanes 5, 6 and 7, DIsd11 monomer co-elutes with a
lesser amount of the other higher molecular weight proteins. There also appears to
be some degradation of DIsd11 monomer. Lanes 4-7 were concentrated and loaded
on a Sephadex 75 column to see if the higher molecular weight bands can be
separated.
In Figure B. lanes 2-8 correspond to different fractions from Sephadex 75 column
chromatography purification. In lanes 7 and 8, ca. 80% pure DIsd11 monomer could
be recovered. However, this was not sufficient for the proposed experiments.
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Figure 2.10: Effect of co-solvents on DIsd11 oligomeric state after two rounds of
purification
In Figure A. lanes 2-10 correspond to different fractions dialysed into buffer
containing various co-solvents. Lanes 2-10 are also labelled A-I on the top of the
gel, where each letter corresponds to the co-solvent used as shown in Table 5. No
major difference was seen in the supposed oligomeric state of the protein.
In Figure B. lanes 2-10 correspond to different fractions dialysed into buffer
containing various co-solvents that were loaded on an SDS-PAGE gel after 48 hours
of incubation at 4ᵒC.
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Buffer

Co-solvent

50mM Tris-HCl, pH 8.0,
1mM ZnSO4, 100mM
KCl

A

5M Urea (Denaturant)

B

10mM DTT (Reducing agent)

C

1% TFA (Stabilizes α helices)

D

1M Cys (DNfs Reaction substrate)

E

10% DMSO (Denaturant)

F

40% Methanol (Salting out)

G

5% Glucose (Reduces aggregation)

H

Control

Table 3: Co-solvent categorization for oligomer stability experiment
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buffer. Many Fe-S cluster assembly proteins are known to bind to Zinc and if this
happens with Isd11 as well, the oligomer stability maybe increased by Zinc.
2.3.4. Western Blot using Anti-His antibody and Anti-Isd11 antibody
The purification results hinted at the immediate need for a Western blot of
the purified Isd11 protein fractions. Two blotting experiments were performed. In
the first experiment, an anti-His primary antibody was used and in the second
experiment, an anti-Isd11 primary antibody was used. The rationale for performing
two blots was preceded by our hypothesis that the four proteins that co-eluted
could be oligomers of Isd11 and that if oligomerized, the His-tag maybe difficult to
detect by the primary anti-His antibody. The anti-His blot revealed only the
monomer of Isd11. However, the anti-Isd11 blot revealed all four co-eluted proteins
in addition to the monomer of Isd11 (Figure 2.11). This confirmed our hypothesis
that the co-eluted proteins are indeed, oligomers of Isd11. However, an alternative
explanation could also mean that the four proteins are cross-reactive proteins of the
anti-Isd11 polyclonal primary antibody.
2.3.5. Circular Dichroism of DIsd11 oligomer-monomer mixture
Once the identity of the purified Isd11 fraction was confirmed, our next aim
was to characterize the folded state of the protein. The averaged CD spectra from
340nm to 180nm (Figure 2.12) suggested that the protein was primarily alpha-helical
in nature (Table 4). However, the saturation of the UV lamp at the end of 180nm
slightly distorted the values to favour beta strands over alpha-helices. This could be
rectified if the saturation can be avoided by identifying the right protein
concentration. Another variable associated with the performed experiment was that
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Figure 2.11: Western Blot film and SDS-PAGE gel showing presence of
oligomers in DIsd11 purified fractions
Figure A. is the Anti-His antibody-tagged Western Blot for the purified DIsd11
protein. Figure B. is the Anti-Isd11 antibody-tagged Western Blot for the
purified DIsd11 protein.
Figure C. is the SDS-PAGE gel corresponding to the Anti-His antibody-tagged
Western Blot. Figure D. is the SDS-PAGE gel corresponding to the Anti-Isd11
antibody-tagged Western Blot.
In all figures, lane 1 is the marker and lane 2 is the DIsd11 protein sample.
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A.
Lanes

1

2

3

B.

Figure 2.12: SDS-PAGE gel and CD spectrum of DIsd11 oligomer and
monomer protein mixture
In Figure A. Lane 2 corresponds to Pre-S75 DIsd11 sample and Lane 3
corresponds to the protein used for the Circular Dichroism experiment.
Figure B. is the averaged CD spectrum of the DIsd11 protein mixture.
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Secondary structure

190-260nm

Standard deviation

α helices

19 %

2%

Antiparallel β

24 %

1%

Parallel β

9%

1%

β-turn

17 %

1%

Random coil

31 %

1%

Table 4: Secondary structure content of DIsd11 protein oligomer-monomer
mixture
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the profile reflects only the folded state of the protein mixture and not the folded
state of the oligomer or monomer individually.
2.4 Future directions
Drosophila Isd11 is an interesting protein that is ca. 40% soluble when grown
in BL21 (DE3) strains of E.coli cell lines. The soluble protein is however, difficult to
purify in any one of its oligomeric states. Another notable feature is that the protein
runs at a molecular weight 4kDa higher than its original molecular weight. This is
consistent with comparisons to induced samples and also from a western blot
experiment. This strange trait could be because of zinc binding to the protein or
some other metabolite from the growth media. None of these possibilities have
been testified and hence, requires further characterization of the protein.
The limited purity of one state of the protein also makes it difficult to predict
the secondary structure of DIsd11 monomer or one oligomer alone using Circular
dichroism. Although we have not been able to isolate one form of the protein from
the soluble fraction in our lab, we have been able to purify the monomer of Isd11
using 8M Urea (data not shown). This rigorous method usually interferes with the
folded state of the protein. Methods to dialyse out the urea using 3kDa MWCO
Centricons or 3kDa MWCO Dialysis bags have not been successful. Interestingly,
dialysis of Urea-purified Isd11 into Urea-free buffer has been successful in the yeast
system when passed through a desalting column and the protein did not oligomerise
on Urea removal. A limitation to this method is however, the limited recovery of
protein as most of the Isd11p (yeast system) precipitates after dialysis. Yet, enough
protein could be recovered for a Circular dichroism experiment. Nevertheless, Ureapurified DIsd11 awaits the same desalting buffer-exchange treatment.
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One useful technique for characterising protein-protein interactions is
Isothermal Titration Calorimetry (ITC). In one of the several ITC experiments
performed in our lab using Urea-purified DIsd11 and Urea-purified DNfs, DIsd11 was
found to interact with DNfs (Drosophila cysteine desulfurase) with μM to nM affinity
in a two-site binding model (data not shown). It was interesting to see an
endothermic profile during the binding event. In addition, DIsd11 showed no binding
if left in Urea for 5-7 days and more. Following ITC, both the proteins were tested
using a cysteine desulfurase activity assay and this revealed that Urea-purified DNfs
was inactive. These results hinted at the limited usefulness of Urea-purified DIsd11
and DNfs for binding characterization and therefore, the ITC experiments were not
pursued further. If a definitive solution is found to remove Urea from the two
proteins, there could be some success in following this strategy for binding
characterization.
In-vivo studies have not yet revealed the exact binding motif of Isd11 with
cysteine desulfurase, Isu[5] and Frataxin[6]. In future, experiments should be
directed towards creating deletion mutants of Isd11 to understand the binding event
in the Fe-S cluster biogenesis complex. The mystery surrounding the functionality of
the Isd11 LYR motif could also be resolved.
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Chapter 3 Characterisation of DNfs
3.1 Prelude
Cysteine desulfurase was the first protein identified and characterised in the
Iron sulphur cluster biogenesis pathway. In every pathway dedicated for iron-sulfur
cluster biogenesis cysteine desulfurase is a common factor and plays the same vital
role of providing sulphur equivalents from cysteine. There is no substitute for
cysteine desulfurase in this pathway and therefore, an abrogation of cysteine
desulfurase is lethal for cell viability [1]. The enzyme is notated in many ways
depending on the pathway or cell-type under consideration. For example, the
enzyme is called NifS (in the NIF pathway), SufS (in the SUF pathway), IscS (in the ISC
pathway), Nfs1p (in yeast) and NifS (in humans)[2]. For convenience, the enzyme will
be called Nfs for the rest of the discussion.
Nfs has been identified in the nucleus, cytosol and mitochondrial matrix. The
enzyme’s localisation in three distinct parts of a cell is concordant with its functional
diversity. This ‘moonlighting’ property of the enzyme is witnessed in tRNA thiolation
and cofactor thiamine biosynthesis[3]. So much has been known about Nfs due to its
structural characterisation. A crystal structure of the bacterial isoform of the
enzyme, IscS was determined in 2001[4]. This led to a greater understanding of many
pathways including the iron-sulfur cluster biogenesis pathway. Structural details
show that Nfs is a homodimeric, PLP-dependent enzyme and each subunit can be
divided into a small domain and a large domain. This feature is characteristic of αfamily type IV aminotransferases of PLP-dependent enzymes. The relevant features
of Nfs with reference to its function are that the large domains of the Nfs dimer
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house the PLP cofactor at the dimer interface. The PLP cofactor is held in place by
the formation of an internal aldimine Schiff base with a lysine residue in the active
site. A reactive cysteine residue present in the small domain of Nfs initiates PLPmediated catalysis. However, the cysteine residue and the PLP cofactor are ~17Aᵒ
apart and require the enzyme to undergo a major conformational change. This is
believed to occur with the help of a flexible loop that connects the large and small
domain. The entire reaction is believed to take place in a β-elimination fashion.
All these facets are true for a prokaryotic system. Although IscS shares a 60%
sequence identity and an 80% sequence similarity with human NifS[4], it remains to
be seen whether the eukaryotic enzyme shares structural similarity with its
prokaryotic isoform. This is important because latest evidence suggests that
eukaryotic cysteine desulfurase is inactive in the absence of an accessory protein
named Isd11, found exclusively in eukaryotes [5]. This intriguing attribute
necessitates biochemical and biophysical characterisation of eukaryotic cysteine
desulfurase. Drosophila cysteine desulfurase was chosen as a model enzyme for
eukaryotes in our lab and will be notated as DNfs in the following discussion.
3.2 Materials and Methods
3.2.1. Cloning of DNfs
DNfs cDNA was obtained in a pOT2 vector, from the “Drosophila Genomic
Research Center” (FlyBase ID: FBgn0032393). The DNfs sequence represents 72bp to
1457bp of the complete 1533bp open reading frame. The first 102bp of the DNfs
cDNA were truncated to improve protein expression and solubility. The truncated
cDNA with 1284bp was PCR amplified, sub-cloned into a pENTR/SD/D-TOPO vector

47

(Invitrogen) and then, recombined into pDest15 and pDest17 vectors (Invitrogen)
using the Gateway Recombination Cloning technology (Invitrogen). The pDest17
vector has a (His)6 tag and pDest15 has a GST tag to enhance protein expression and
purification. The pDest clones were first transformed into DH5α cloning strain
(Invitrogen) for amplification and later transformed into BL21-AI E.coli competent
cells. Positive clones were verified by DNA sequencing (Genewiz facility). The
recombinant plasmid was transformed into BL21-AI (Invitrogen) and BL21 (DE3)
E.coli competent cell lines for protein expression.
Alternatively, a DNfs cDNA clone with 1284bp cloned by a previous graduate
student, Dr. Swati Rawat, was also available. The truncated cDNA was cloned into
pET151/D-TOPO vector (Invitrogen) and transformed into BL21 (DE3) cell line.
3.2.2. Optimization of soluble protein expression
The truncated DNfs protein (Δ1-34 DNfs) was expected to have 429 amino
acids and a molecular weight of 47.46kDa (minus the expression tag). None of the
clones created by Gateway Recombination cloning technology could be expressed in
the transformed BL21 cell lines. The next step was to optimize protein expression
using the alternative DNfs clone in pET151/D-TOPO vector (Invitrogen). For
convenience, this clone will be referred to as Δ1-34 DNfs2 for the rest of the
discussion. Soluble protein expression from Δ1-34 DNfs2 could not be optimized by
varying IPTG concentrations, post-induction time intervals, pre-induction OD and
temperatures. Based on the overall protein expression (despite the fact that the
yield of soluble protein was extremely low), few conditions could be chosen for large
scale protein expression and purification. For subsequent Δ1-34 DNfs protein
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expression, Δ1-34 DNfs2 in BL21 (DE3) was grown at 37°C till an OD of 0.8-0.9 and
then induced with 0.2mM IPTG for ca. 3-4 hours before harvesting by centrifugation.
3.2.3. Protein purification of soluble Δ1-34 DNfs2
Protein isolation steps were all performed at 4° C. Cells were resuspended in
50 mM Na3PO4 (pH 7.4), 300 or 500mM NaCl, 20 mM Imidazole and 5 mM β-Me in
the presence of Complete EDTA-free Protease inhibitor cocktail (Roche). A 20μg/mL
of DNase and 5mM MgCl2 were added before lysis to reduce viscosity of the medium
at the time of filtration. Cells were then lysed by two passes through a French Press
cell at high pressure (1100 psi), and centrifuged at high speed (21000 rpm) for 1
hour. Crude soluble fraction was filtered (0.20 μm) and loaded onto a HisPur Ni-NTA
column (Thermo Scientific) using an Imidazole gradient in the range of 0 – 500 mM.
The available soluble Δ1-34 DNfs2 containing fractions were pooled and
concentrated to ca. 1mL by centrifugation using 10kDa Molecular Weight Cut Off
(MWCO) centricons (Millipore) spun at 5000 rpm. The concentrated retentive
solution was run over a HiLoad 16/10 Superdex 75 size exclusion column (General
Electronics) equilibrated with 50mM Na3PO4 buffer (pH 7.4), 500 mM NaCl. The
fractions obtained were analysed on 10% or 4-20% SDS-PAGE gels (Bio-Rad).
3.2.4. Auto-induction protocol for soluble Δ1-34 DNfs2 expression
For the Auto-induction protocol, fresh media was prepared using 5g
BactoTryptone, 2.5g Bacto-Yeast extract, 1M MgSO4, 50X 5052 (0.5% Glycerol, 0.05%
Glucose and 0.2% α-lactose), 20X NPS (0.5M Ammonium sulphate, 1M Potassium
phosphate dibasic and 1M Sodium phosphate monobasic) and 100mg/mL Ampicillin.
The medium was inoculated with a starter culture and allowed to grow at 27ᵒC for
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24 hours. After 24 hours, the cultures were harvested by centrifugation. Protein
purification was then performed by the already described protocol.
3.2.5. Double-colony selection for soluble Δ1-34 DNfs2 expression
The Δ1-34 DNfs2 gene in pET151/D-TOPO was first transformed into
BL21(DE3) competent cell lines and positive clones were selected. One half of the
selected colonies were grown at 37ᵒC till an OD of 0.8-0.9 and then induced with
0.2mM IPTG for ca. 3-4 hours. The other half was then re-plated on a fresh LB agar
plate coated with Ampicillin. Fresh positive clones were selected and expressed
again at the above-mentioned conditions.
3.3 Results
3.3.1. Cloning of DNfs
N-terminal truncation of proteins is a common strategy used in labs to
improve solubility of proteins. Experimental evidence in the yeast model suggests
that Nfs is insoluble in its native form. Therefore, the same strategy was used for our
Drosophila model. Using ‘Mitoprot’ software the first 34 amino acids at the Nterminus were found to be the mitochondrial targeting sequence (MTS) and could be
safely removed without altering the functionality of the protein. Truncated DNfs (Δ134) was successfully cloned into pENTR/SD/D-TOPO vector, recombined into pDest15
and pDest17 vectors, restriction digested after cloning and sequence analysed to
confirm the presence of the gene in the vector (Figure 3.1). The sequence analysis of
the pDest15 clone required further verification as the T7 forward primer could not
detect the first part of the gene due to the large GST tag sequence. On sequence
verification of the gene in pDest17, it was confirmed that the selected DH5α cloning
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Figure 3.1: Sequence verification of pDest17 Δ1-34 DNfs clone

‘DNfspmd’ is the DNfs sequence available in Pubmed and ‘Nfsp17C2’ is the
sequence of the newly cloned DNfs gene.
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strain transformant and the BL21-AI expression strain transformant had the right
clone. The pDest17 positive clones were selected and also transformed into
BL21(DE3) expression strain for protein expression. The Δ1-34 DNfs2 clone was also
transformed into BL21(DE3) for protein expression.
3.3.2. Optimization of soluble protein expression
Different expression conditions were tried and yet, none of the colonies with
positive clones expressed Δ1-34 DNfs (Figure 3.2). The reason for the lack of protein
expression could not be tracked. Contrary to these unexpected results, the Δ1-34
DNfs2 clone was able to express protein in the BL21(DE3) expression strain.
However, ca. 95% of the protein expressed from BL21(DE3) was insoluble (Figure
3.3B). The clone was also transformed into BL21(DE3)-RIL and BL21(DE3)-Rossetta
expression strains; but the results did not vary (Figure 3.3A). Based on overall
protein expression the Δ1-34 DNfs2 clone in BL21(DE3) was used for subsequent
large scale protein expression and purification and was grown at 37ᵒC at a preinduction OD of 0.8-0.9 and induced with 0.2mM IPTG for 3-4 hours. The protein
with its His6 tag was expressed at a molecular weight corresponding to ca. 48kDa.
3.3.3. Protein purification of soluble Δ1-34 DNfs2
Protein purification was the next step and after two rounds of purification
through HisPur Ni-NTA and HiLoad 16/10 Superdex 75 columns, no pure protein
could be isolated. The protein consistently eluted out with ca. 80% of bacterial
proteins (Figure 3.4). A possible reason for the inability to purify Δ1-34 DNfs2 could
be the drop of protein pI from 8.40 in its native form to 6.58 in its Δ1-34 truncated
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Figure 3.2: SDS-PAGE gel showing Δ1-34 DNfs expression of pDEST15 and
pDEST17 clones in BL21(DE3) cell lines
Figure A. shows DNfs expression from the pDEST15 clone in a BL21(DE3) cell
line. Lanes 2-5, 6-8 and 9-11 correspond to different expression conditions.
Figure B. shows DNfs expression from the pDEST17 clone in a BL21(DE3) cell line.
Lanes 2-5 and 6-9 correspond to different expression conditions. Both gels
indicate that there is no protein expression under standard expression
conditions for both the clones.
In both figures, ‘PI’ stands for Pre-induced, ‘I’ stands for Induced, ‘S’ stands for
Supernatant and ‘P’ stands for Pellet.
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Figure 3.3: SDS-PAGE gel showing Δ1-34 DNfs2 protein expression from a
pET151-D-TOPO clone in BL21(DE3), BL21(DE3)-RIL and
BL21(DE3)-Rosetta cell lines
Lanes 2-5 in Figure A. corresponds to Δ1-34 DNfs2 protein expression in
BL21(DE3)-RIL cell line. Lanes 6-9 in Figure A. corresponds to protein
expression in BL21(DE3)-Rossetta cell line.
Lanes 2-13 in Figure B. corresponds to Δ1-34 DNfs2 protein expression in
BL21(DE3) cell line.
In both figures, ‘PI’ stands for Pre-induced, ‘I’ stands for Induced, ‘S’ stands
for Supernatant and ‘P’ stands for Pellet.
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form. With repeated attempts at large scale protein expression and purification we
concluded that it was not worth pursuing the large scale expression the truncated
form of DNfs using conventional strategies.
3.3.4. Auto-induction for soluble Δ1-34 DNfs2 expression
The Auto-induction protocol caused lesser bacterial protein expression than
Δ1-34 DNfs2 (Figure 3.5). This was an improvement from the conventional strategy
of IPTG-induced expression. However, on lysis and protein purification sufficient
soluble protein could not be recovered and purified. This suggests that although the
overall protein expression is high, most of the protein is insoluble.
3.3.5. Double colony selection for soluble Δ1-34 DNfs2 expression
By the end of the second round of colony selection and expression, the
intensity of a lower band ca. 30kDa in size was much more than the first round of
selection and expression (Figure 3.6). This lower band is speculated to be a
degradation product of the truncated protein when expressed in BL21(DE3).
However, this hypothesis can be confirmed only if a Western Blot of the expressed
protein sample is carried out.
3.4 Future Directions
DNfs is an extremely insoluble protein and could not be purified with a
conventional strategy of IPTG induction or even, auto-induction. 26.4% of amino
acids in the native state of the protein are positively and negatively charged
residues. In the truncated form of the protein as well, 26.57% of amino acids are
positively and negatively charged residues (ExPASy ProtParam program). A key point
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Figure 3.4: Soluble Δ1-34 DNfs2 protein purification using His-Co column
affinity chromatography and S75 Size-exclusion chromatography
In Figure A., lanes 2-10 (or E1-E9) correspond to different fractions eluted
from a HisPur Ni-NTA column at a pH of 7.4. Lanes E3-E9 show that the Δ1-34
DNfs monomer protein (ca. 48kDa with the His tag) was hardly expressed in
the soluble form and co-eluted with many bacterial proteins after this affinity
chromatography purification step. Lanes E5-E9 were concentrated and
loaded onto a HiLoad 16/10 Superdex 75 size-exclusion chromatography
column.
In Figure B., lanes 2-10 (or E1-E7) correspond to different fractions from S75
size-exclusion chromatography. Soluble protein could not be purified even
after the second stage of purification.
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Figure 3.5: Auto-induction of Δ1-34 DNfs2 protein expression
Figure A. shows Δ1-34 DNfs2 protein expression after induction and at different
stages of lysis. ‘R’ stands for Resuspension, ‘L’ stands for Lysate, ‘S’ for
Supernatant and ‘P’ for Pellet.
Figure B. shows different fractions after His Ni-NTA affinity purification. Two
bench-type columns were used for this task. A1-A7 represent fractions from one
column and B1-B5 represent fractions from the second column. So, essentially
both columns had the same soluble Δ1-34 DNfs2 extract after cell lysis.
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Figure 3.6: Δ1-34 DNfs2 protein expression after Double colony selection
Figure A. shows protein expression after the first round of colony selection.
Lanes represent protein expression in 5 different colonies. The numbers
corresponding to each lane represent the colony identity. Figure B. shows
protein expression after the second round of colony selection. Four colonies
were selected for protein expression. There was no improvement in protein
expression.
In both gels, ‘PI’ stands for Pre-induced and ‘I’ stands for Induced.
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to be noted is that the theoretical pI of the protein drops from 8.40 in its native state
to 6.58 in its truncated form. The impact of this change in pI could influence
solubility. After cloning the truncated form of the gene, one feature was noted on
close observation. In both the Δ1-34 DNfs-pDest17 clone and the Δ1-34 DNfs2pET151/D-TOPO clone, a substitution mutation occurred at exactly one amino acid
after cloning. In the first clone, the last amino acid histidine was substituted to
glutamine and in the second clone, the 384th amino acid, arginine was substituted to
cysteine. It is interesting to see if the mutation occurs due to the genetic machinery
of the DH5α cloning strain. Whether this single amino acid mutation causes a major
change in expression and solubility is a question that needs to be addressed.
The lack of soluble protein expression in few conventional E.coli expression
systems renders Δ1-34 DNfs2 an unfit clone to work with unless a novel strategy is
identified. An alternative strategy could involve creating different truncations of the
gene like Δ1-37 DNfs, Δ1-60DNfs or any other truncation before the 70 th amino acid.
The reason for restricting truncations to the 70 th amino acid originates from a
comparison with the crystal structure of IscS, E.coli cysteine desulfurase. Recent
evidence in the yeast model suggests that mitochondrial cysteine desulfurase
undergoes two truncations at its N-terminal sequence by two different processing
enzymes – MPP (Mitochondrial Processing peptidase) and Icp55[6]. The second
truncation apparently occurs after the Mitochondrial Targeting Sequence (MTS) is
cleaved off. The Mitoprot program does not account for the second truncation while
calculating the MTS. In yeast Nfs1p, Icp55 cleaves off three amino acids after the
MTS. The same rationale has been used to suggest a Δ1-37 DNfs truncation.
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Evidence in the human and yeast systems suggest that different isoforms of cysteine
desulfurase arise from a single transcript by alternative utilisation of in-frame AUGs
[7]. This means that the mitochondrial and nuclear forms of the protein arise from
the same transcript. Therefore, creating a Δ1-60DNfs truncation would be another
useful strategy.
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Chapter 4 Summary
4.1 Characterisation of DIsd11
Drosophila was chosen as our model organism for two main reasons. Firstly,
many geneticists have used Drosophila to study neurodegenerative disorders and
the organism seems to be an excellent model for these. Secondly, previous studies in
our lab with Drosophila proteins like Dfh (Frataxin) and DIsu (Isu homolog), both of
which are involved in iron-sulphur cluster biogenesis pathway have shown that the
proteins are more stable when purified. Such a stable system was required for our
characterisation of Isd11 and Nfs, as proteins that form a complex are known to be
labile in the absence of its partner. Yeast-based studies have shown signs of
degradation or aggregation of Nfs in the absence of Isd11, so there is a question of
extended sample integrity for the yeast proteins. Our first protein characterised in
this research project was DIsd11.
DIsd11 could be expressed well in an E.coli expression strain BL21(DE3). The
solubility of the protein improved only at low IPTG concentrations and could be
stably expressed at 37ᵒC. The induction time was also lowered to reduce
precipitation and the insoluble form of the protein. This observation was consistent
even on a large scale. Once soluble DIsd11 was obtained, the next step was to purify
the protein, which proved to be a challenging task. Two rounds of purification
involving His-Co purification in the first step and Superdex 75 Size exclusion
chromatography in the second step were used, and yet pure protein could not be
obtained. Several different strategies were adopted and repeated failed attempts
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suggested to us that we need to perform a Western Blot to identify the nature of the
rest of the co-eluted proteins. Surprisingly, all the major co-eluted proteins were
detected on an Anti-Isd11 Western Blot. This gave us increasing confidence to use
the protein mixture containing possible oligomers and the monomer of DIsd11 for
Circular Dichroism. However, such a CD experiment could only detect the overall
secondary structure of DIsd11 and lacked specificity.
Latest developments in our lab using Desalting columns for buffer-exchange
have allowed YIsd11 recovery from Urea-solubilised insoluble YIsd11. CD profiles of
the so-obtained re-folded protein show a high degree of proper folding. This strategy
needs to be followed in future for proper secondary structure characterisation of
DIsd11 as well. Interestingly, YIsd11 does not oligomerise on re-folding. Future
characterisation of the Isd11 protein should focus on the reasons for Isd11
oligomerisation in vitro. In addition, the function of the LYR motif needs to be
predicted and also, the exact binding sites of Isd11 on Nfs for cysteine desulfurase
activity.
4.2 Characterisation of DNfs
Simultaneously, DNfs needed to be characterised for any subsequent
biophysical characterisation of the Cysteine desulfurase complex with Isd11. DNfs
offered a bigger challenge than DIsd11. The protein showed signs of expression but
almost 95% of the protein accumulated in the insoluble fraction. Insoluble proteins
normally assemble in a cell as inclusion bodies and are difficult to re-fold back to the
native state. However, in a series of purification protocols, DNfs was extracted from
inclusion bodies using 6 - 8M Urea. All refolding attempts culminated in the
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precipitation of the protein and loss of activity. So, expression conditions and
purification protocols had to be designed to produce large amounts of soluble
protein.
All proteins targeted for the mitochondria show a high degree of floppiness in
its N-terminal Mitochondrial Targeting Sequence (MTS) and surprisingly, MTS
removal is found to improve protein solubility. So, the first 34 amino acids of DNfs
were removed and the newly cloned gene had only 429 amino acids. Expression
tests suggested that the protein could be expressed well; but, the issue of solubility
persisted even after truncation.
Various expression protocols like the auto-induction protocol and doublecolony selection were performed in addition to the conventional method of IPTG
induction. None of these protocols showed promising results. With the little protein
available, protein purification was also tried. Protein solubility tremendously
influenced the outcome of purification and hence, yielded no pure protein. It
appears as though the native form of DNfs and its truncated version are poor models
for DNfs characterisation using E.coli. Site-directed mutagenesis experiments need
to be performed to recreate the original DNfs gene from the single amino acid
mutated DNfs clones to verify the above conclusion. If mammalian cell lines or other
eukaryotic cell lines are not used, DNfs characterisation may continue to pose
problems in future. However, this does not mean that alternative truncations of the
protein like Δ1-37 or Δ1-60 DNfs would not improve expression and solubility in
E.coli. Comparisons with the crystal structure of the bacterial counterpart, IscS allow
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us to truncate amino acids till the 60th residue without altering the function of the
protein. Hence, these strategies are also worth exploring.
4.3 Characterisation of both the proteins
Simple ITC experiments have been performed in our lab using Urea-purified
Δ1-34 DNfs2 and DIsd11. One of the trials showed a high endothermic heat
absorption when Urea-purified DIsd11 was titrated into Urea-purified Δ1-34 DNfs2.
Unfortunately, these experiments were not pursued further because the enzyme
appeared to be thoroughly unfolded. A binding event alone was not enough for our
hypothesis. Our aim was to use the native state of both proteins and predict the
binding event as well as conformational changes during persulfide formation. The
results from this strategy would be more conclusive when coupled with the cysteine
desulfurase activity assay as opposed to using Urea-denatured proteins.
A simple remedy to the problem of expressing both the proteins separately
and then allowing complexation would be co-expression of both proteins on one
vector. This would enable characterisation of the oligomeric state of the Isd11cysteine desulfurase complex. Other important features of the entire Iron-sulfur
cluster assembly complex can also be studied. There are still certain features of the
complex that can be estimated only if both the proteins are expressed and purified
individually, unless one figures out how to separate both proteins from the complex.
One such important study would be an isothermal titration calorimetry experiment
which estimates the binding affinity of both proteins for each other. This can also
roughly predict the number of binding sites on Nfs for Isd11. This technique is also
useful to predict the ability of any of these proteins to bind to metals like zinc or
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nickel, which is a quality commonly found among proteins involved in Fe-S cluster
biogenesis.
Until a crystal structure is obtained, it would be worthwhile trying to predict
the exact binding motifs within Nfs on which Isd11 monomer units bind. For this
approach, multiple segments of Nfs will have to be dissected and cloned separately.
Following this step, protein pull-down assays can be performed to estimate the exact
binding motif. It is interesting to see where exactly Nfs incorporates Isd11 in its
dimeric structure because the protein is already known to bind to five other
proteins.
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Iron-sulfur clusters are cofactors with evolutionary origins that date back to
the pre-biotic world. Ever since life originated, these cofactors have intermingled
with proteins to play vital roles in sustaining life. My research focuses on one such
protein, the cysteine desulfurase (Nfs) that has the PLP cofactor incorporated in its
active site and avails of the catalytic property of PLP to provide sulphur for Ironsulfur cluster biogenesis and assembly in a cell. Interestingly, in a eukaryotic cell,
despite the versatility of PLP, cysteine desulfurase’s role as a “sulphur-extractor” is
incomplete without another protein named Isd11. This interesting piece of evidence
led us to perform basic protein characterisation of both the proteins so as to
biophysically study the binding event and conformational changes during persulfide
formation in future. We chose Drosophila as our model organism. We have been
able to successfully create a working model for further characterisation of the
binding event during persulfide formation.
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